SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 13 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 660 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 660 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 660 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -83.3% | 660 | -76.9% | 0.00% | – |
| Q4 2017 | $6,000 | +500.0% | 2,860 | +748.7% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 337 | -57.3% | 0.00% | – |
| Q1 2016 | $2,000 | -50.0% | 789 | +3.5% | 0.00% | – |
| Q4 2015 | $4,000 | 0.0% | 762 | 0.0% | 0.00% | – |
| Q3 2015 | $4,000 | -33.3% | 762 | +3.4% | 0.00% | – |
| Q2 2015 | $6,000 | +500.0% | 737 | +130.3% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 320 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 320 | 0.0% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 320 | 0.0% | 0.00% | – |
| Q2 2014 | $1,000 | -50.0% | 320 | 0.0% | 0.00% | – |
| Q1 2014 | $2,000 | – | 320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,200,000 | $6,072,000 | 2.38% |
| GREAT POINT PARTNERS LLC | 2,175,000 | $6,003,000 | 2.15% |
| Belmont Global Advisors, Inc. | 400,000 | $1,104,000 | 1.12% |
| Trellus Management Company, LLC | 162,900 | $450,000 | 0.78% |
| PURA VIDA INVESTMENTS, LLC | 572,800 | $1,581,000 | 0.72% |
| DAFNA Capital Management LLC | 294,563 | $813,000 | 0.70% |
| Twin Securities, Inc. | 1,687,115 | $4,656,000 | 0.58% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 1,000,000 | $2,760,000 | 0.33% |
| WALL STREET ASSOCIATES | 269,300 | $743,000 | 0.31% |
| Paulson & Co. | 11,090,000 | $30,608,000 | 0.23% |